Comparative abilities of athymic nude mice and severe combined immune deficient (SCID) mice to accept transplants of induced rat mammary carcinomas: enhanced transplantation efficiency of those rat mammary carcinomas that have elevated expression of neu oncogene
- PMID: 8097186
- DOI: 10.1002/ijc.2910530624
Comparative abilities of athymic nude mice and severe combined immune deficient (SCID) mice to accept transplants of induced rat mammary carcinomas: enhanced transplantation efficiency of those rat mammary carcinomas that have elevated expression of neu oncogene
Abstract
Grafts of primary carcinogen (DMBA)-induced mammary carcinomas from Sprague-Dawley rats have a poor transplantation efficiency in athymic nude mice. Further compromising these mice immunologically via whole-body irradiation and/or splenectomy, or the administration of hormonal growth factors (estrogen and progesterone) to these mice, did not significantly alter transplantation efficiency. Use of strains of mice that are more immune-impaired than the athymic nude mouse, i.e., the athymic nude-beige-XID mouse (T-cell and LAK-cell deficient) or mice with severe combined immune deficiency (SCID) (which lack functional T cells and B cells) also failed to improve transplantation efficiency. In contrast, transplantation efficiency was sharply increased when primary neu-induced rat mammary carcinomas from female Sprague-Dawley rats were used. These mammary carcinomas, unlike the DMBA-induced rat mammary carcinomas, have a very high level of expression of neu; transplantation of these tumors to either athymic nude mice or SCID mice was considerably more efficient. Thus, these data provide evidence that enhanced expression of neu confers heightened efficiency in the transplantation of primary rat mammary carcinomas to immune-deficient mice (athymic-nude or SCID). Increased neu expression was a greater determinant than more compromised immune states in the transplantation of these rat mammary carcinomas. This biological characteristic of neu expression in mammary carcinomas provides new, additional insight into the importance of this oncogene in mammary tumorigenic processes and may explain, at least in part, the reported inverse relationship between human breast carcinoma neu expression and patient prognosis.
Similar articles
-
Normal but not carcinomatous primary rat mammary epithelium: readily transplanted to and maintained in the athymic nude mouse.J Natl Cancer Inst. 1987 Mar;78(3):557-65. J Natl Cancer Inst. 1987. PMID: 3102827
-
Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.Cancer Res. 1993 May 15;53(10 Suppl):2272-8. Cancer Res. 1993. PMID: 8097963
-
Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy.Cancer Res. 1992 Aug 1;52(15):4102-5. Cancer Res. 1992. PMID: 1353410
-
Mechanisms of hormonal prevention of breast cancer.Ann N Y Acad Sci. 2001 Dec;952:23-35. doi: 10.1111/j.1749-6632.2001.tb02725.x. Ann N Y Acad Sci. 2001. PMID: 11795441 Review.
-
[Animal experimental models of breast cancer for therapeutic testing of hormones and antihormones].Arch Geschwulstforsch. 1988;58(5):345-56. Arch Geschwulstforsch. 1988. PMID: 3060043 Review. German.
Cited by
-
Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.In Vitro Cell Dev Biol Anim. 2000 Jul-Aug;36(7):410-27. doi: 10.1290/1071-2690(2000)036<0410:EMAIDO>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2000. PMID: 11039493
-
Animal models of breast cancer for the study of pathogenesis and therapeutic insights.Clin Transl Oncol. 2009 Nov;11(11):721-7. doi: 10.1007/s12094-009-0434-7. Clin Transl Oncol. 2009. PMID: 19917535 Review.
-
Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.Breast Cancer Res Treat. 1996;39(1):69-86. doi: 10.1007/BF01806079. Breast Cancer Res Treat. 1996. PMID: 8738607 Review.
-
Induction of ductal carcinomas by intraductal administration of 7,12-dimethylbenz(a)anthracene in Wistar rats.Breast Cancer Res Treat. 1995 Apr;34(1):35-43. doi: 10.1007/BF00666489. Breast Cancer Res Treat. 1995. PMID: 7749158
-
Interleukin-33 increases the sensitivity of multiple myeloma cells to the proteasome inhibitor bortezomib through reactive oxygen species-mediated inhibition of nuclear factor kappa-B signal and stemness properties.MedComm (2020). 2024 May 9;5(5):e562. doi: 10.1002/mco2.562. eCollection 2024 May. MedComm (2020). 2024. PMID: 38737470 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous